Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02696239 · ClinicalTrials.gov registry record · NA

Vaginal Cuff Closure in Robotic Hysterectomy

A NA study of Complications of Medical Care, sponsored by Henry Ford Health System.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT02696239: Completed NA study of Complications of Medical Care, sponsored by Henry Ford Health System.

NCT02696239 is a NA study of Complications of Medical Care that has completed, run by Henry Ford Health System. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02696239, a NA study of Complications of Medical Care, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the impact of implementing different types of suturing materials and techniques of vaginal cuff closure in robotic assisted laparoscopic hysterectomy on cost, operative time and post operative surgical outcomes.

Primary Outcome

Postoperative inspection for vaginal cuff dehiscence

Interventions

  • DEVICE V-lock suture
  • DEVICE Vicryl Suture
  • DEVICE Lapra-Ty II

Study Locations (1)

Michigan

  • Henry Ford Hospital - Detroit

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2010-09
Est. Completion 2016-02
Phase NA
Henry Ford Health System

234 total trials

What the finished NCT02696239 record still lists

NCT02696239 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Complications of Medical Care appearing as the primary indexed condition, and to 3 interventions - of which V-lock suture is the first listed.

NCT02696239 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT02696239 about?

NCT02696239 is a clinical study titled "Vaginal Cuff Closure in Robotic Hysterectomy". The purpose of this study is to evaluate the impact of implementing different types of suturing materials and techniques of vaginal cuff closure in robotic assisted laparoscopic hysterectomy on cost, operative time and post operative surgical outcomes.

What is the current status of trial NCT02696239?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2010-09. Estimated completion is 2016-02.

What conditions does trial NCT02696239 study?

This clinical trial studies the following conditions: Complications of Medical Care.

What interventions are being tested in trial NCT02696239?

The interventions under investigation include: V-lock suture (DEVICE), Vicryl Suture (DEVICE), Lapra-Ty II (DEVICE).

Who is sponsoring clinical trial NCT02696239?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02696239 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02696239's enrollment target sits among peer trials

90 941st of 2000 higher than 1,029 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02696239, the US trial registry maintained by the National Library of Medicine. NCT02696239 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.